Aye, I understand..
My uhhmm..scenarios descriptions to the other post are real situations that could occur and would place a brick in the critical pathway of OCATA reaching their ultimate milestones in any year??
Believe me there is so much else involved. Even if approved, Doctors would still have to be trained on a relatively simple needle injection process into the fovea in the proper dosage for maximum coalescence.... yadda, yadda....
Which to me, Makes sense that OCATA has recently hired the 3 marketers (pun intended) to smooth the pathway in a few years.....
In other words OCATA is finally thinking out of the past box, looking into the future box, crossing their T's and setting up a facility to supply the market base that will come a calling (IF they receive FDA approval in 2019/2020).
And yes...It could be sooner if the EMA slides them in around 2017-2018....Then the FDA should follow in suit way before 2019-2020....
My few cents in the biggest down market in the last 18 months in a nut shell for now....
